Goossens D, Champomier F, Rouger P, Salmon C
J Immunol Methods. 1987 Aug 3;101(2):193-200. doi: 10.1016/0022-1759(87)90150-5.
The EBV immortalization technique was used to produce stable clones, from B lymphocytes, secreting human monoclonal antibodies to Rh(D), Rh(G), Rh(c), Rh(E), Kell, A and A1 blood group antigens. These clones were obtained from peripheral blood lymphocytes of hyperimmunized plasmapheresis donors or from spleen lymphocytes of immunized patients. Mean levels of antibody concentration varied between 4 and 50 micrograms/ml. The antibodies obtained were of IgG1, IgG2, IgM or IgA class. Most of the clones have been stable for growth and antibody production during long periods of continuous culture, extending upto 4 years. Hybridization of two clones was effected with the human lymphoblastoid cell line KR-4 and with the mouse myeloma X63-Ag8.653, but did not result in any marked improvement of clone characteristics. One of the anti-Rh(D)-producing EBV-transformed clones was used to produce an anti-Rh(D) typing reagent which has proved satisfactory for 2 years in routine blood typing in several laboratories.
采用EBV永生化技术从B淋巴细胞中制备稳定克隆,这些克隆可分泌针对Rh(D)、Rh(G)、Rh(c)、Rh(E)、凯尔(Kell)、A及A1血型抗原的人单克隆抗体。这些克隆来自超免疫血浆置换供者的外周血淋巴细胞或免疫患者的脾淋巴细胞。抗体浓度的平均水平在4至50微克/毫升之间。所获得的抗体属于IgG1、IgG2、IgM或IgA类。大多数克隆在长达4年的连续长期培养过程中生长和抗体产生都很稳定。将两个克隆与人淋巴母细胞系KR-4及小鼠骨髓瘤X63-Ag8.653进行杂交,但克隆特性未得到任何显著改善。其中一个产生抗Rh(D)的EBV转化克隆被用于制备一种抗Rh(D)定型试剂,该试剂在多个实验室的常规血型鉴定中已被证明在两年内效果令人满意。